Strachinaru Mihai, Castro-Rodriguez Jose, Verbeet Thierry, Gazagnes Marie-Dominique
Cardiology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Cardiology, Brugmann University Hospital, Brussels, Belgium.
Arch Cardiovasc Dis. 2017 Apr;110(4):250-258. doi: 10.1016/j.acvd.2017.01.001. Epub 2017 Feb 21.
The left atrial septal pouch (LASP) is formed by incomplete fusion of the septum primum and septum secundum, leaving a cavity open towards the left atrium, but without interatrial shunting. There is no recommendation concerning strategy in the presence of a LASP, especially in the setting of stroke. The aim of this review was to determine whether the LASP could be incriminated as the aetiology of a stroke. We included all pertinent publications on the subject, and calculated hazard ratios for ischaemic stroke and cryptogenic stroke. There were only five case-control studies concerning the LASP, involving 516 stroke patients and 779 controls. Overall LASP prevalence was 21%, with a slightly higher prevalence in the cryptogenic stroke group (26%), but this difference was not statistically significant (P=0.27). In a random-effects meta-analysis, there was no difference between controls and patients with ischaemic stroke (hazard ratio 1.20, 95% confidence interval 0.96-1.53; P=0.14). Cryptogenic stroke appeared more frequently in patients with LASP (hazard ratio 1.53, 95% confidence interval 1.07-2.24; P=0.02), but this was driven by only one severely underpowered study. The published case reports demonstrated that thrombus formation inside the pouch can occur in the presence of major predisposing factors. The LASP can be a site for thrombus formation, leading to embolic events, but its presence does not correlate with an increased incidence of stroke. Associated factors should be taken into consideration in the setting of stroke. Further studies are necessary to validate a possible relationship with cryptogenic stroke.
左心房间隔袋(LASP)由原发隔和继发隔不完全融合形成,形成一个向左心房开放的腔,但无房水平分流。对于存在LASP的情况,尤其是在卒中背景下,尚无关于治疗策略的推荐。本综述的目的是确定LASP是否可被认定为卒中的病因。我们纳入了所有关于该主题的相关出版物,并计算了缺血性卒中和隐源性卒中的风险比。关于LASP的病例对照研究仅有5项,涉及516例卒中患者和779例对照。LASP总体患病率为21%,隐源性卒中组患病率略高(26%),但差异无统计学意义(P = 0.27)。在随机效应荟萃分析中,对照组与缺血性卒中患者之间无差异(风险比1.20,95%置信区间0.96 - 1.53;P = 0.14)。LASP患者中隐源性卒中出现更频繁(风险比1.53,95%置信区间1.07 - 2.24;P = 0.02),但这仅由一项样本量严重不足的研究驱动。已发表的病例报告表明,在存在主要易感因素时,袋内可形成血栓。LASP可能是血栓形成的部位,导致栓塞事件,但它的存在与卒中发病率增加无关。在卒中背景下应考虑相关因素。需要进一步研究来验证与隐源性卒中可能存在的关系。